Confirmed on the employer's own hiring board on Nov 9, 2026. First seen by Alion on Nov 9, 2026.
Job Summary
The Project Manager will coordinate the initial cross-functional assessment of nitrosamine
risk for biotherapeutic products, including proteins and cell and gene therapies. The
immediate objective is to determine whether existing paper-based risk assessments and
supporting documentation remain adequate against current regulatory expectations, and
to define any evidence gaps, potential follow-up work, and an indicative scope and
resource estimate. This is an assessment-first role; confirmatory testing or remediation
should not be assumed.
Key Responsibilities
Stakeholder coordination: Partner with the designated Biotherapeutics leads to
identify and engage the relevant drug substance, drug product, MSAT Material
Sciences, and R&D Material Sciences SMEs, keeping outreach focused on the
assessment.
- Assessment workplan: Establish a focused workplan with clear owners,
milestones, decisions, and dependencies that leads to an initial scope and
resource estimate, aligned with the existing Synthetics nitrosamine program.
- Evidence review: Under SME direction, coordinate the review of existing
biotherapeutics nitrosamine risk evaluations, underlying assumptions, and
supporting evidence, including material, process, water, packaging, and storage
inputs.
- Technical discussions: Arrange targeted technical discussions and document
decisions, open questions, evidence requests, and follow-up actions. Facilitate
comparison of assumed biotherapeutics nitrosamine levels against Synthetics
assumptions, and of assumed versus measured Synthetics levels.
- Gap assessment: Track SME conclusions on whether existing paper-based
evaluations are sufficient. Where gaps are identified, coordinate definition of any
further assessment, testing, or remediation needs, distinguishing between lifecycle
management products and products in development.
- Decision-ready reporting: Consolidate agreed findings, open questions, options,
indicative scope, timing, and resource needs into a concise, decision-ready update
with clear ownership of next steps. Technical conclusions and testing decisions
remain with the accountable SMEs.
Skill Requirements
Mandatory: Direct, hands-on experience with nitrosamine risk assessment or
related investigations for biotherapeutic products (e.g., proteins, monoclonal
antibodies, cell and gene therapies, or antibody-drug conjugates). General biologics
experience, or nitrosamine experience limited to Synthetics, does not meet this
requirement.
- Project management or coordination experience in a GMP biopharmaceutical
environment, including cross-functional document review, action tracking, and
evidence-based scope planning.
- Working knowledge of biotherapeutic drug substance and drug product risk factors,
nitrosamine assessment documentation, and the distinction between risk
evaluation, confirmatory testing, and remediation.
- Demonstrated ability to work effectively with scientific, quality, and regulatory
SMEs; translate technical discussions into a clear plan and resource estimate; and
manage sensitive scope questions without making scientific or regulatory decisions
on their behalf

